Combining endocrine and chemotherapy - Any true benefits?

M. E. Lippman, A. Buzdar, D. C. Tormey, W. L. McGuire

Research output: Contribution to journalArticle

6 Scopus citations

Abstract

There is abundant evidence for a good response rate to combination chemotherapy in advanced breast cancer, and to endocrine therapy as well if the tumor is receptor-positive. The unresolved issue is whether patient outcomes, such as survival, are improved by combining these two separate approaches. Do the higher complete and partial response rates to combined chemo-endocrine therapy result in longer survival than when these therapies are used in sequence? Can appropriate endocrine manipulation sensitize tumor cells to subsequent treatment? Could there be some disadvantage to combining endocrine and chemotherapy? These questions are discussed here by a selected panel.

Original languageEnglish (US)
Pages (from-to)251-259
Number of pages9
JournalBreast cancer research and treatment
Volume4
Issue number4
DOIs
StatePublished - Jan 1 1984

    Fingerprint

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Lippman, M. E., Buzdar, A., Tormey, D. C., & McGuire, W. L. (1984). Combining endocrine and chemotherapy - Any true benefits? Breast cancer research and treatment, 4(4), 251-259. https://doi.org/10.1007/BF01806036